Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
Background and Purpose: Olfactory dysfunction (OD) is a common non-motor symptom of Parkinson disease (PD). However, the relationship between OD and neuropathologic proteins in cerebrospinal fluid (CSF) from PD patients remains unclear.Methods: 166 PD patients were included in the study. Overall olf...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2020.594324/full |
id |
doaj-90d8329be4b6412b92092384c5f09383 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Peng Guo Rui-dan Wang Teng-hong Lian Du-yu Ding Ya-nan Zhang Wei-Jiao Zhang Dan-ning Li Li-xia Li Jing-hui Li Hui-ying Guan Shu-yang Yu Li Liu Yang Hu Li-jun Zuo Qiu-jin Yu Xiao-min Wang Wei Zhang Wei Zhang Wei Zhang Wei Zhang |
spellingShingle |
Peng Guo Rui-dan Wang Teng-hong Lian Du-yu Ding Ya-nan Zhang Wei-Jiao Zhang Dan-ning Li Li-xia Li Jing-hui Li Hui-ying Guan Shu-yang Yu Li Liu Yang Hu Li-jun Zuo Qiu-jin Yu Xiao-min Wang Wei Zhang Wei Zhang Wei Zhang Wei Zhang Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease Frontiers in Aging Neuroscience Parkinson disease olfactory dysfunction sniffin' sticks test cerebrospinal fluid neuropathologic proteins |
author_facet |
Peng Guo Rui-dan Wang Teng-hong Lian Du-yu Ding Ya-nan Zhang Wei-Jiao Zhang Dan-ning Li Li-xia Li Jing-hui Li Hui-ying Guan Shu-yang Yu Li Liu Yang Hu Li-jun Zuo Qiu-jin Yu Xiao-min Wang Wei Zhang Wei Zhang Wei Zhang Wei Zhang |
author_sort |
Peng Guo |
title |
Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease |
title_short |
Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease |
title_full |
Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease |
title_fullStr |
Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease |
title_full_unstemmed |
Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease |
title_sort |
olfactory dysfunction and its association with neuropathologic proteins in cerebrospinal fluid from patients with parkinson disease |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Aging Neuroscience |
issn |
1663-4365 |
publishDate |
2020-12-01 |
description |
Background and Purpose: Olfactory dysfunction (OD) is a common non-motor symptom of Parkinson disease (PD). However, the relationship between OD and neuropathologic proteins in cerebrospinal fluid (CSF) from PD patients remains unclear.Methods: 166 PD patients were included in the study. Overall olfactory function was assessed by summing up the scores of olfactory threshold, discrimination, and identification by a Sniffin' Sticks test, based on which, patients were divided into PD with OD (PD-OD) and PD with no OD (PD-NOD) groups. CSF samples were obtained from 76 PD patients. The levels of neuropathologic proteins, including α-Synuclein, Aβ1-42, total tau (T-tau), and multiple forms of phosphorylated tau (P-tau) in CSF were measured by an enzyme-linked immunosorbent assay.Results: out of the 166 PD patients, 103 cases (62.0%) had OD. The scores of overall olfactory functions, and olfactory threshold, discrimination, and identification in the PD-OD group were all significantly lower than that in the PD-NOD group (P < 0.001). α-Synuclein level in CSF was significantly higher in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and negatively correlated with the scores of overall olfactory function, and olfactory discrimination and identification (P < 0.05). Aβ1-42 level in CSF was higher in the PD-OD group than the PD-NOD group, and was significantly and negatively correlated with the olfactory identification score (P < 0.05). T-tau level in CSF was significantly lower in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and positively correlated with the olfactory discrimination score (P < 0.05). There was no significant difference in P-tau level in CSF between the PD-OD and PD-NOD groups and no correlation between OD score and P-tau level in CSF.Conclusions: PD-OD includes the impairments of olfactory threshold, discrimination, and identification, and is associated with the significant elevation of α-Synuclein and the decrease of the T-tau level in CSF. |
topic |
Parkinson disease olfactory dysfunction sniffin' sticks test cerebrospinal fluid neuropathologic proteins |
url |
https://www.frontiersin.org/articles/10.3389/fnagi.2020.594324/full |
work_keys_str_mv |
AT pengguo olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT ruidanwang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT tenghonglian olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT duyuding olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT yananzhang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT weijiaozhang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT danningli olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT lixiali olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT jinghuili olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT huiyingguan olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT shuyangyu olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT liliu olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT yanghu olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT lijunzuo olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT qiujinyu olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT xiaominwang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT weizhang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT weizhang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT weizhang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease AT weizhang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease |
_version_ |
1724386802760941568 |
spelling |
doaj-90d8329be4b6412b92092384c5f093832020-12-11T06:08:35ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652020-12-011210.3389/fnagi.2020.594324594324Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson DiseasePeng Guo0Rui-dan Wang1Teng-hong Lian2Du-yu Ding3Ya-nan Zhang4Wei-Jiao Zhang5Dan-ning Li6Li-xia Li7Jing-hui Li8Hui-ying Guan9Shu-yang Yu10Li Liu11Yang Hu12Li-jun Zuo13Qiu-jin Yu14Xiao-min Wang15Wei Zhang16Wei Zhang17Wei Zhang18Wei Zhang19Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Blood Transfusion, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of General Internal Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of General Internal Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Physiology, Capital Medical University, Beijing, ChinaDepartment of Neurology, Center for Cognitive Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaCenter of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing, ChinaBeijing Key Laboratory on Parkinson Disease, Beijing, ChinaBackground and Purpose: Olfactory dysfunction (OD) is a common non-motor symptom of Parkinson disease (PD). However, the relationship between OD and neuropathologic proteins in cerebrospinal fluid (CSF) from PD patients remains unclear.Methods: 166 PD patients were included in the study. Overall olfactory function was assessed by summing up the scores of olfactory threshold, discrimination, and identification by a Sniffin' Sticks test, based on which, patients were divided into PD with OD (PD-OD) and PD with no OD (PD-NOD) groups. CSF samples were obtained from 76 PD patients. The levels of neuropathologic proteins, including α-Synuclein, Aβ1-42, total tau (T-tau), and multiple forms of phosphorylated tau (P-tau) in CSF were measured by an enzyme-linked immunosorbent assay.Results: out of the 166 PD patients, 103 cases (62.0%) had OD. The scores of overall olfactory functions, and olfactory threshold, discrimination, and identification in the PD-OD group were all significantly lower than that in the PD-NOD group (P < 0.001). α-Synuclein level in CSF was significantly higher in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and negatively correlated with the scores of overall olfactory function, and olfactory discrimination and identification (P < 0.05). Aβ1-42 level in CSF was higher in the PD-OD group than the PD-NOD group, and was significantly and negatively correlated with the olfactory identification score (P < 0.05). T-tau level in CSF was significantly lower in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and positively correlated with the olfactory discrimination score (P < 0.05). There was no significant difference in P-tau level in CSF between the PD-OD and PD-NOD groups and no correlation between OD score and P-tau level in CSF.Conclusions: PD-OD includes the impairments of olfactory threshold, discrimination, and identification, and is associated with the significant elevation of α-Synuclein and the decrease of the T-tau level in CSF.https://www.frontiersin.org/articles/10.3389/fnagi.2020.594324/fullParkinson diseaseolfactory dysfunctionsniffin' sticks testcerebrospinal fluidneuropathologic proteins |